HPV vaccinations among teens in the US dropped precipitously during the early pandemic, a disappointing reversal for shots that can prevent more than 33,000 cases of cancer each year. Worse, efforts to get vaccinations back on track could be stymied by legal challenges.
We can’t let a decade worth of slow and steady progress in HPV vaccinations be lost.
Getting the US public to accept the HPV vaccine as a safe and effective part of routine health care has been a decade-long slog. That effort involved allaying (unfounded) beliefs that these shots, by preventing HPV, could encourage sexual activity among teens. That’s because the virus excels at spreading through skin-to-skin contact — so much so that nearly everyone is exposed, perhaps more than once, during their lifetime. And while the immune system can get rid of the infection most of the time, certain strains can stick around for years, kicking off a process that morphs otherwise healthy cells into cancerous ones.